ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,400, issued on Feb. 10, was assigned to University of Utah Research Foundation (Salt Lake City).
"Treatment of myopic progression" was invented by Randon Michael Burr (Salt Lake City), Balamurali K. Ambati (Sandy, Utah) and Sarah A. Molokhia (Sandy, Utah).
According to the abstract* released by the U.S. Patent & Trademark Office: "An ophthalmic composition or dosage form can include a therapeutically effective amount of a copper-containing agent that is sufficient to increase corneal lysyl oxidase activity in an eye of a subject in an amount sufficient to treat myopic progression and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat or pre...